Sally Egginton

701 citations
5 papers · 600 · 1 hit paper · h-index 4

Impact in

    • Systemic Lupus Erythematosus Research
  • Physiology top 10%
    • Alzheimer's disease research and treatments

Papers in

Sally Egginton

5 papers receiving 581 citations

Sally Egginton's Hit Papers

A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea 2018 · 251 citations
2510+2+5Years since publication50100150200250

Peers

Sally Egginton
Comparison fields: 5 of 45
  • Rheumatology 263
  • Physiology 205
  • Psychiatry and Mental health 102
  • Neurology 31
  • Endocrinology, Diabetes and Metabolism 20
Replace Pietro Barbacini with:
Pietro Barbacini Italy
Norimichi Shirafuji Japan
Joana Menezes Sweden
Sylvia Stoeckler-Ipsiroglu Austria
Natan Brand Israel
Tiziana Giuliano Italy
Serena Sensi United Kingdom
Dorcas Y. Koenigsberger United States
E.P. Frakes United States
Asako Horino Japan
Sally Egginton relative to Pietro Barbacini Italy Pietro Barbacini's profile →
Citations per field
00.5×5×11.3×
Pietro Barbacini · 1×
Citations per year

Countries citing papers authored by Sally Egginton

Since Specialization
Citations

This map shows the geographic impact of Sally Egginton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Egginton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Egginton more than expected).

Fields of papers citing papers by Sally Egginton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Egginton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Egginton. The network helps show where Sally Egginton may publish in the future.

Co-authors

The 20 scholars most cited alongside Sally Egginton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sally Egginton Line = papers co-authored together Sally Egginton links everyone, so they are left out of the graph.

All Works

5 of 5 papers shown
#Work
1 2010319
2
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea
Hit paper breakdown →
2018251
3 201815
4 201913
5 20172

About Sally Egginton

Sally Egginton is a scholar working on Rheumatology, Psychiatry and Mental health, Physiology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 5 papers that have together received 600 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (4 papers), Alzheimer's disease research and treatments (1 paper) and Dementia and Cognitive Impairment Research (1 paper). The work is most often cited by research in Rheumatology (263 citations), Physiology (205 citations), Psychiatry and Mental health (102 citations), Neurology (31 citations) and Endocrinology, Diabetes and Metabolism (20 citations). Sally Egginton has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Gary E. Landreth, Yoshiya Tanaka, Ann M. Saunders, Claire Alderton, David A. Roth, Marina E. Zvartau-Hind, Myron Chu, Sharon T. Sawchak, Damon Bass and Suzanne Craft. Their work appears in journals such as Modern Rheumatology, Dementia and Geriatric Cognitive Disorders and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact